Joseph W. Stauffer

发表

Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations

Richard E. White, M. Rowbotham, E. Kalso, 2014, PAIN®.

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

J. Farrar, N. Bellamy, B. Galer, 2003, Pain.

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.

David Cella, Charles S Cleeland, Alejandro R Jadad, 2008, The journal of pain : official journal of the American Pain Society.

What is sufficient evidence for the reliability and validity of patient-reported outcome measures?

Ron D Hays, R. Hays, B. Reeve, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations

Jennifer A. Haythornthwaite, Richard W. Foltin, George E. Bigelow, 2012, PAIN®.

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations

Richard E. White, J. Heyse, J. Chandler, 2008, PAIN.

Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations.

Richard E. White, Christopher L. Wu, E. Kalso, 2016, Pain.

Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users

L. Webster, F. Johnson, Joseph W. Stauffer, 2011, Drugs in R&D.

Poster 238: Efficacy and Tolerability of ALO-01 (Morphine Sulfate Extended-Release With Sequestered Naltrexone Hydrochloride) Capsules in Patients With Chronic Moderate-to-Severe Pain From Osteoarthritis of the Hip or Knee

Nathaniel Katz, Joseph W. Stauffer, D. L. Morris, 2008 .

The Role of Urine Drug Testing for Patients on Opioid Therapy

J. Pergolizzi, Joseph W. Stauffer, M. Brennan, 2010, Pain practice : the official journal of World Institute of Pain.

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations

Richard E. White, J. Farrar, N. Bellamy, 2010, PAIN®.

Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules.

F. Johnson, Joseph W. Stauffer, G. Wagner, 2008, The journal of pain : official journal of the American Pain Society.

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

J. Farrar, N. Bellamy, B. Galer, 2003, Pain.

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations

Richard E. White, J. Farrar, R. Gershon, 2006, Pain.

Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers.

F. Johnson, J. Stark, Joseph W. Stauffer, 2010, Clinical Therapeutics.

(260) Efficacy and safety evaluation of an extended-release morphine sulfate formulation with sequestered naltrexone for the treatment of osteoarthritis

F. Johnson, Nathaniel Katz, Joseph W. Stauffer, 2008 .

Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double‐blind, placebo‐controlled trial

E. Viscusi, M. Torjman, Joseph W. Stauffer, 2021, Clinical and translational science.

ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety.

F. Johnson, Nathaniel Katz, Joseph W. Stauffer, 2010, The journal of pain : official journal of the American Pain Society.

The Relative Bioavailability of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules (EMBEDA®) and an Extended Release Morphine Sulfate Capsule Formulation (KADIAN®) in Healthy Adults Under Fasting Conditions

F. Johnson, Joseph W. Stauffer, J. Kisicki, 2011, American journal of therapeutics.

Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltrexone, in patients with chronic, moderate to severe pain.

R. Brewer, L. Webster, F. Johnson, 2010, Journal of pain and symptom management.

Food effects on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules

F. Johnson, Joseph W. Stauffer, S. Boudriau, 2010, Advances in therapy.

Erratum to: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, doubleblind, placebo-controlled, crossover study

Joseph W. Stauffer, B. Setnik, M. Sokołowska, 2009, Clinical drug investigation.

Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users

E. Sellers, F. Johnson, Joseph W. Stauffer, 2009, Clinical drug investigation.

Effects of Alcohol on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules

F. Johnson, Joseph W. Stauffer, J. Kisicki, 2012, Journal of clinical pharmacology.

Statement nterpreting the Clinical Importance of Treatment Outcomes n Chronic Pain Clinical Trials : IMMPACT Recommendations

K. Schmader, J. Chandler, J. Farrar, 2008 .

Determining the clinically important difference in visual analog scale scores in abuse liability studies evaluating novel opioid formulations

D. Revicki, S. Comer, Nathaniel Katz, 2012, Quality of Life Research.

SAFETY AND ANTI-PRURITIC EFFICACY OF A MENTHOL-CONTAINING MOISTURIZING CREAM

H. H. Andersen, R. Spencer, J. Elberling, 2015 .

Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules in Patients with Chronic Osteoarthritis Pain

Nathaniel Katz, Joseph W. Stauffer, M. Hale, 2010, Postgraduate medicine.

Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells.

G. Striker, L. Agodoa, T. Doi, 1989, The Journal of clinical investigation.

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations

Richard E. White, J. Farrar, N. Bellamy, 2010, PAIN®.

ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety.

F. Johnson, Nathaniel Katz, Joseph W. Stauffer, 2010, The journal of pain : official journal of the American Pain Society.